Education Dinner IMBRUVICA (ibrutinib) with a focus on CLL/SLL ad MCL; Tacoma, WA, 9/20 (Non-PSONS)

Posted on 13. Sep, 2017 by in non-PSONS

You are invited to attend an educational event on IMBRUVICA (ibrutinib) with a focus on CLL/SLL ad MCL

Program Overview:
Imbruvica: overview, MOA, clinical trial data
Dosing, Administration, Safety, Patient support

Presented by:
John Pagel, MD PhD
Medical Director
Swedish Cancer Institute
Seattle WA

Wednesday, September 20, 2017
6:00 pm registration
6:30 pm presentation

1924 Pacific Avenue
Tacoma WA 98402

RSVP to:

You may also RSVP to:
Molly Bissett 206-651-1581

Click here to download the flyer: Pagel Tacoma 9 20 17

Comments are closed.